All News

Patsy Williams received her kidney from her brother, Barry Ford, 40 years ago at Vanderbilt University Medical Center.

Kidney transplant patient, brother share 40-year journey

In 1979, Patsy Williams and her brother, Barry Ford, made a decision that has given her many more years of life.
Ford gave Williams his kidney at Vanderbilt University Medical Center. They recently gathered for a luncheon to celebrate the 40th anniversary of Williams’ transplant, along with dozens of their closest friends and family. She is thought to have lived longer with her transplant than anyone else who received one at Vanderbilt.

More congenital heart patients becoming transplant candidates

Patients with a form of congenital heart disease — having only one ventricle (pumping chamber) — are now living longer lives due to the successful surgical and medical treatments they receive as children.

Kristie Kuzy decided to donate a kidney to a stranger. Her generosity initiated the first three-recipient kidney transplant chain in the history of Vanderbilt University Medical Center.

The amazing and improbable story of how it all fell into place

Study merges big data and zebrafish biology to reveal mechanisms of human disease

In a series of studies that volleyed between large databases and research in zebrafish, Vanderbilt investigators have discovered a link between vascular biology and eye disease.

Transplant centers, patients unite to stop new organ sharing policy that threatens longer waits for a liver

Vanderbilt University Medical Center and 13 other highly regarded liver transplant centers have filed a lawsuit aimed at stopping Federal policy changes that are slated to take effect Tuesday, April 30, that will affect thousands of patients across the Southeast and Midwest waiting for donor livers.

From left, Benjamin Brown, Christine Lovly, MD, PhD, Yun-Kai Zhang, PhD, Jens Meiler, PhD, and colleagues are exploring new ways to understand resistance to targeted cancer therapy drugs.

Study reframes approach to targeted therapy resistance

When a tumor mutates and develops resistance to a targeted therapy, researchers often focus on the acquisition of new mutations within the drug target as they seek an alternative treatment, but a team of Vanderbilt scientists has shown this may not be sufficient.

1 123 124 125 126 127 144